泰恩康(301263.SZ)公告,近日,江苏省医疗保障局发布《第二、四批国家组织药品集中带量采购协议期满后(江苏)接续采购公告(三)》,公司全资子公司山东华铂凯盛生物科技有限公司(“华铂凯盛”)申报的他达拉非片(商标名:爱廷威®)拟中选。该药物主要用于治疗男性勃起功能障碍(ED),包装规格2片/盒,拟中选价48元/盒,年度意向采购数量10.1347万片。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台用户上传并发布,不构成投资建议请自行甄别,如有侵权请联系删除:liaycn@163.com
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of the site, which is a social media platform and only provides information storage services.